| scholarly article | Q13442814 |
| P50 | author | Emine Çiloğlu | Q88404525 |
| P2093 | author name string | Ayse Yıldırım Celikdemir | |
| P2860 | cites work | Follow up by colour Doppler imaging of 102 patients with retinal vein occlusion over 1 year | Q30503125 |
| Color Doppler imaging of ocular blood flow after combined photodynamic therapy with intravitreal triamcinolone in age-related macular degeneration. | Q51528212 | ||
| A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion. | Q53199049 | ||
| Initial color Doppler findings in retinal vein occlusion. | Q54068381 | ||
| Color Doppler imaging of arterial blood flow in central retinal vein occlusion. | Q54198020 | ||
| Response of Retinal Vessels and Retrobulbar Hemodynamics to Intravitreal Anti-VEGF Treatment in Eyes with Branch Retinal Vein Occlusion | Q60699442 | ||
| Risk factors for central retinal vein occlusion. The Eye Disease Case-Control Study Group | Q71054248 | ||
| [Color Doppler ultrasonography in the study of orbital and ocular vascular diseases] | Q71321557 | ||
| Central retinal vein occlusion, an investigation by color Doppler imaging. Blood velocity characteristics and prediction of iris neovascularization | Q71640373 | ||
| Doppler assessment of hemodynamic changes after hemodilution in retinal vein occlusion | Q74313410 | ||
| Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab | Q80193496 | ||
| Hemodynamic response to intravitreal triamcinolone in eyes with macular edema: intravitreal triamcinolone and ocular blood flow | Q80342977 | ||
| Evaluation of renal artery stenosis with hemodynamic parameters of Doppler sonography | Q81679191 | ||
| Testing the effectiveness of intravitreal ranibizumab during 12 months of follow-up in venous occlusion treatment | Q85888310 | ||
| Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies | Q90024592 | ||
| Experimental central retinal vein occlusion. A comparison of intraocular and extraocular occlusion | Q93781792 | ||
| The role of vascular endothelial growth factor in angiogenesis | Q34111713 | ||
| Doppler ultrasound and renal artery stenosis: An overview. | Q34327106 | ||
| Short-term effects of intravitreal triamcinolone acetonide injection on ocular blood flow evaluated with color Doppler ultrasonography | Q34390554 | ||
| Changes in retinal blood flow in patients with macular edema secondary to branch retinal vein occlusion before and after intravitreal injection of bevacizumab | Q35181334 | ||
| Arterial blood flow characteristics in central retinal vein occlusion and effects of panretinal photocoagulation treatment: an investigation by colour Doppler imaging | Q35307146 | ||
| Retinal Vein Occlusion | Q35821104 | ||
| A "throttle" mechanism in the central retinal vein in the region of the lamina cribrosa | Q35953980 | ||
| Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach | Q36220942 | ||
| POOLED ESTIMATES OF INCIDENCE OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS WITH AND WITHOUT TOPICAL ANTIBIOTIC PROPHYLAXIS. | Q36299232 | ||
| Therapies for Macular Edema Associated with Branch Retinal Vein Occlusion: A Report by the American Academy of Ophthalmology | Q36383445 | ||
| Color Doppler imaging of retinal diseases | Q37729460 | ||
| Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE. | Q38708331 | ||
| New Developments in the Classification, Pathogenesis, Risk Factors, Natural History, and Treatment of Branch Retinal Vein Occlusion | Q38848800 | ||
| Can intramuscular corticosteroid injection cause nonarteritic anterior ischemic optic neuropathy? | Q39568413 | ||
| A role for VEGF as a negative regulator of pericyte function and vessel maturation | Q39919369 | ||
| Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway | Q40856400 | ||
| Colour Doppler assessment of blood flow in eyes with central retinal vein occlusion | Q44122192 | ||
| Ultrasound assessment of short-term ocular vascular effects of intravitreal injection of bevacizumab (Avastin(®) ) in neovascular age-related macular degeneration. | Q45948046 | ||
| Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration. | Q45949982 | ||
| Ischaemic change after intravitreal bevacizumab (Avastin) injection for macular oedema secondary to non-ischaemic central retinal vein occlusion | Q46583701 | ||
| Multiple retinal haemorrhages in diabetic retinopathy after adjunctive intravitreal bevacizumab (Avastin) with pars plana vitrectomy | Q46841456 | ||
| The effects of intravitreous bevacizumab on retinal neovascular membrane and normal capillaries in rabbits | Q46868929 | ||
| Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries | Q46926870 | ||
| Effects of Intravitreal Dexamethasone Implants on Retinal Oxygen Saturation, Vessel Diameter, and Retrobulbar Blood Flow Velocity in ME Secondary to RVO. | Q47606105 | ||
| Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF. | Q48269441 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | dexamethasone | Q422252 |
| aflibercept | Q4689286 | ||
| P304 | page(s) | 823-830 | |
| P577 | publication date | 2019-07-04 | |
| P1433 | published in | Therapeutics and Clinical Risk Management | Q15766913 |
| P1476 | title | The short-term effects of intravitreal aflibercept injections and dexamethasone implant on ocular hemodynamics in retinal vein occlusions | |
| P478 | volume | 15 |
Search more.